Dextrose Monohydrate 50% Injection shortage
Dextrose Monohydrate 50% Injection is currently listed in shortage by the FDA. The FDA lists 4 affected products. The reported reason: Other. This page was last refreshed from FDA data on Oct 2, 2026.
Dextrose 50% injection (dextrose monohydrate) is in a lasting shortage, with one strength — the 0.5 g/mL ABBOJECT® glass syringe — having no available source from reporting makers. Other strengths, including 25 g/50 mL, are still listed by ICU Medical and RemedyRepack.
Don’t stop or change your therapy on your own — talk with your prescriber about the plan that fits you, and ask your pharmacist what’s actually available (see options).
Do you take this drug? See the ‘What to do’ recommendation from Dr. Brian Staiger, PharmD →What’s in shortage — at a glance
These figures count only the manufacturers that reported this shortage to the FDA — not every company that makes Dextrose Monohydrate 50% Injection. Other makers that haven’t reported a problem are shown in the green card below.
Shortage timeline
-
Sep 22, 2026Currently in shortage4 of 4 products affected.
-
Sep 16, 2026FDA refreshed this shortage record1 product updated.
-
Aug 24, 2026FDA refreshed this shortage record1 product updated.
-
Nov 7, 2025FDA refreshed this shortage record1 product updated.
-
Nov 7, 2025More presentations reported1 more product added to the shortage.
-
Jan 13, 2022First reported to the FDA3 products first listed.
Built from FDA posting and update dates. The end date FDA publishes is the posting/update date, not a true resolution date, so durations are approximate.
What exactly is on backorder — by manufacturer
Manufacturer: Amphastar Pharmaceuticals, Inc. 📞 800-423-4136 1 NDC click to expand
| Status | NDC / product | Strength | Availability | Related information | Reason |
|---|---|---|---|---|---|
| Current | Dextrose Monohydrate 50%, Injection, 25 g/50 mL (NDC 76329-3302-1) | — | Available | — | — |
Manufacturer: Hospira, Inc., a Pfizer Company 📞 844-646-4398 3 NDCS click to expand
| Status | NDC / product | Strength | Availability | Related information | Reason |
|---|---|---|---|---|---|
| Current | Dextrose Monohydrate 50%, Injection, 25 g/50 mL (NDC 0409-7517-16) | — | Available | — | — |
| Current | Dextrose Monohydrate 50%, Injection, 25 g/50 mL (NDC 0409-6648-02) | — | Limited Availability | Next Delivery: November 2026; Estimated Recovery: December 2026. Shortage per Manufacturer: Manufacturing Delay | Other |
| To Be Discontinued | Dextrose Monohydrate 50%, Injection, 50% Dextrose Injection 0.5 g/mL; ABBOJECT® Glass Syringe (NDC 0409-4902-34) | — | — | Discontinuation of the manufacture of the drug | — |
These rows are manufacturer reports to the FDA for Dextrose Monohydrate 50% Injection — they do not necessarily cover every manufacturer that makes this drug. A company appears here only if it told the FDA it has a supply problem, so other makers may still have stock. That’s the basis for the Where else can I get Dextrose Monohydrate 50% Injection? options further down this page.
Why is Dextrose Monohydrate 50% Injection in shortage?
For one of Hospira/Pfizer's versions of this product — the 25 g/50 mL vial (NDC 0409-6648-02) — there's been a hold-up at their manufacturing facility, which has limited how much is available right now. According to Hospira, they expect their next delivery in November 2026, with supply expected to recover by December 2026. It's worth knowing that Hospira's other 25 g/50 mL presentation (NDC 0409-7517-16) is currently available from them, and Amphastar's 25 g/50 mL version is available as well.
Hospira is also permanently stopping production of their 50% Dextrose ABBOJECT® Glass Syringe (0.5 g/mL). That specific package — the prefilled glass syringe format — is being discontinued by the manufacturer, meaning they don't plan to make it again. The FDA listed the overall reason category as "Other," so beyond what's noted above, Hospira hasn't shared additional public details about what caused the manufacturing delay.
Based on the manufacturer-reported reason(s) and notes on file with the FDA for Dextrose Monohydrate 50% Injection, summarized in plain English by HelloPharmacist. A drug can be short for more than one reason, and the FDA updates these as manufacturers report changes.
What should I do if I take Dextrose Monohydrate 50% Injection?
Dextrose Monohydrate 50% Injection is currently on the FDA shortage list. If you or the person you care for uses this medicine, the supply picture depends on which form you take, and I want to walk you through it clearly.
The 25 g/50 mL vial still has an available source — both manufacturers on this record report supply, though one delivery is running behind, with an estimated recovery around December 2026. The older 50% Dextrose 0.5 g/mL ABBOJECT® glass syringe, however, is listed as being discontinued by its manufacturer, so that particular form may not return. The overall reason reported to the FDA is listed only as "other," and this shortage has lasted more than a year.
Here is what I suggest, in order:
- Do not stop, skip, or change your dose on your own.
- If you use the 25 g/50 mL form, ask your pharmacy to order it — they can check wholesalers and both manufacturers.
- The same medicine is also made by ICU Medical and RemedyRepack; your pharmacy may be able to source one of these, though it may not be in local stock.
- If your exact form (the ABBOJECT® syringe) cannot be found, talk with your prescriber or pharmacist about a suitable option.
Manufacturer contact numbers are listed on this page for reference, though pharmacies usually handle those calls. This is general, national data and may not match your local pharmacy's stock.
- Don’t stop or change the medication on your own — talk to your prescriber first.
- If this is part of an ongoing or essential regimen (for example HIV treatment or prevention, seizure, heart, transplant, diabetes or mental-health medicines), do not skip or ration doses — contact your pharmacist or prescriber right away to arrange continued supply before you run out.
- Ask your pharmacy to check other manufacturers, strengths, package sizes, and nearby stores.
- Ask your prescriber whether a different strength, formulation, or the brand/generic version is appropriate.
Uses, dosing, side effects, prices, and the complete FDA label — written in plain English and pharmacist-reviewed.
Where else can I get Dextrose Monohydrate 50% Injection?
FDA shortages are manufacturer-reported — a company only shows up on the shortage list if it told the FDA it has a supply problem, so not every maker of Dextrose Monohydrate 50% Injection is necessarily short. Below we pull together the other still-marketed options that are not reported in shortage: the same medicine from manufacturers that haven’t reported a problem, and alternative dosage forms. These may still be out of stock at your pharmacy, and only your prescriber or pharmacist can decide what’s right for you.
Same medicine, other manufacturers (not reported short)
Same active ingredient, dosage form & route as the shortage (matched on the FDB HICL ingredient code), from makers that have not filed a shortage with the FDA:
| Product | Strength | Form / route | Manufacturer | NDC |
|---|---|---|---|---|
| Dextrose | DEXTROSE MONOHYDRATE 50 g/100mL | Injection, Solution · Intravenous | ICU Medical Inc. | 00990-7936-19 |
| Dextrose | DEXTROSE MONOHYDRATE 25 g/50mL | Injection, Solution · Intravenous | REMEDYREPACK INC. | 70518-4219-00 |
Therapeutic equivalents & pricing 15 productsclick to expand
Orange Book–rated equivalents of the affected strengths, with the latest NADAC price (a federal retail-acquisition benchmark, not your copay) and an evidence-based availability label. Cheapest first.
| Product | Manufacturer | Package | NADAC $/unit | AB rating | Availability |
|---|---|---|---|---|---|
| Dextrose 25 g/50mL | Henry | 1 syringe | — | — | FDA listed |
| Dextrose 25 g/50mL | Hospira, | 1 syringe | — | — | FDA listed |
| 50% Dextrose 25 g/50mL | HF | 1 syringe | — | — | FDA listed |
| Dextrose Monohydrate 25 g/50mL | HF | 1 syringe | — | — | Discontinued |
| Dextrose monohydrate 25 g/50mL | HF | 1 syringe | — | AP | FDA listed |
| Dextrose 25 g/50mL | REMEDYREPACK | 1 syringe | — | — | FDA listed |
| Dextrose 25 g/50mL | Medical | 1 syringe | — | — | FDA listed |
| Dextrose 25 g/50mL | Medical | 1 syringe | — | — | FDA listed |
| Dextrose Monohydrate 25 g/50mL | Medical | 1 syringe | — | AP | FDA listed |
| Dextrose Monohydrate 25 g/50mL | International | 1 syringe | — | AP | FDA listed |
| Dextrose 25 g/50mL | ProPharma | 50 ml | — | — | FDA listed |
| Dextrose 25 g/50mL | Medical | 1 vial | — | — | FDA listed |
| Dextrose 25 g/50mL | Henry | 1 vial | — | — | FDA listed |
| Dextrose 25 g/50mL | Hospira, | 25 vials | — | — | FDA listed |
| Dextrose 25 g/50mL | HF | 50 ml | — | — | FDA listed |
Equivalents share the same ingredient, strength, dosage form and route; an AB rating means the FDA considers them substitutable. NADAC is a national retail-pharmacy acquisition benchmark from CMS — not what you pay. Availability is inferred from recent pricing, not a stock check.
Other drugs in the same treatment class
These are different medicines — not other versions of Dextrose Monohydrate 50% Injection — that fall in the same broad treatment class (iv solutions: dextrose-water) . They are not automatic substitutes: they can differ in how they work, dosing, effectiveness, side effects and what they’re approved to treat. Do not switch on your own. This list is for information only — ask your prescriber or pharmacist whether any of them is appropriate for you.
Identity & classification
Where does this data come from?
Other endocrinology/metabolism, gastroenterology, pediatric shortages
Dextrose Monohydrate 50% Injection shortage FAQs
Is Dextrose Monohydrate 50% Injection in shortage?
Why is Dextrose Monohydrate 50% Injection in shortage?
Which products are affected?
When will Dextrose Monohydrate 50% Injection be available again?
Can I still get Dextrose Monohydrate 50% somewhere?
What should I do if I take Dextrose Monohydrate 50% Injection?
Still have a question about the Dextrose Monohydrate 50% Injection shortage?
Ask a pharmacist about this shortage →View Dextrose Monohydrate 50% Injection on the FDA drug-shortage database →
Where does this data come from?
/drug/shortages) — drug, manufacturer & contact, NDC/product, status, availability, reason, therapeutic category and posting/update dates. Current / To Be Discontinued = active; Resolved is kept for history. The Supply-Risk rating is assessed per active ingredient and adds the FDA NDC Directory (still-marketed manufacturers by ingredient & form); same-medicine and equivalent products use First Databank classification + CMS NADAC pricing; Medicaid use + most-affected states come from CMS Medicaid State Drug Utilization Data. Reference only — confirm current status with the manufacturer or FDA before acting on it.